Analysis suggested that the signal transducer and activator of transcription (STAT)/Janus kinase (JAK) pathway activation in the GATA3 regulatory network is a reliable mechanism for combining high expression of GATA3 with ALL and therapy response. This evidence concerns the gene SOAT1 and acute lymphoblastic leukemia.